Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder, characterized by amyloid-β deposition, tau pathology, neuroinflammation, and metabolic dysfunction. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.